• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纯化的人羧肽酶原U的蛋白水解激活

Proteolytic activation of purified human procarboxypeptidase U.

作者信息

Schatteman K A, Goossens F J, Scharpé S S, Hendriks D F

机构信息

From the Department of Clinical Biochemistry, University of Antwerp, Universiteitsplein 1, B-2610, Wilrijk, Belgium.

出版信息

Clin Chim Acta. 2000 Feb 25;292(1-2):25-40. doi: 10.1016/s0009-8981(99)00205-3.

DOI:10.1016/s0009-8981(99)00205-3
PMID:10686274
Abstract

Carboxypeptidase U (CPU, EC 3.4.17.20) is a recently described basic carboxypeptidase which circulates in plasma as an enzymatically inactive precursor procarboxypeptidase U (proCPU), also known as plasma carboxypeptidase B precursor or thrombin activatable fibrinolysis inhibitor (TAFI). The activation of the zymogen proceeds through a proteolytic cleavage at Arg-92. The active form - CPU - is able to retard the initial phase of fibrinolysis by cleaving C-terminal lysine residues exposed on fibrin partially degraded by the action of plasmin. These C-terminal lysine residues are essential for the high affinity binding of plasminogen to fibrin and the subsequent activation to plasmin. In this report, the activation of purified human proCPU was studied using trypsin and some key proteases of the coagulation and fibrinolytic cascade, i.e., kallikrein, plasmin and thrombin. The most efficient activation is obtained in the presence of thrombin in complex with thrombomodulin. After in vitro activation, CPU is unstable at 37 degrees C (T(1/2)=15 min). Its stability can be improved dramatically using lower temperatures.

摘要

羧肽酶U(CPU,EC 3.4.17.20)是一种最近被描述的碱性羧肽酶,它以无酶活性的前体羧肽酶U(proCPU)的形式在血浆中循环,proCPU也被称为血浆羧肽酶B前体或凝血酶激活的纤维蛋白溶解抑制剂(TAFI)。酶原的激活通过在精氨酸92处的蛋白水解切割进行。活性形式——CPU——能够通过切割纤溶酶作用后暴露在部分降解的纤维蛋白上的C末端赖氨酸残基来延缓纤维蛋白溶解的初始阶段。这些C末端赖氨酸残基对于纤溶酶原与纤维蛋白的高亲和力结合以及随后激活为纤溶酶至关重要。在本报告中,使用胰蛋白酶以及凝血和纤维蛋白溶解级联反应的一些关键蛋白酶,即激肽释放酶、纤溶酶和凝血酶,研究了纯化的人proCPU的激活。在凝血酶与血栓调节蛋白形成复合物的情况下可获得最有效的激活。体外激活后,CPU在37℃时不稳定(半衰期T(1/2)=15分钟)。使用较低温度可显著提高其稳定性。

相似文献

1
Proteolytic activation of purified human procarboxypeptidase U.纯化的人羧肽酶原U的蛋白水解激活
Clin Chim Acta. 2000 Feb 25;292(1-2):25-40. doi: 10.1016/s0009-8981(99)00205-3.
2
Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma.人血浆中纤溶酶原激活物抑制因子U(纤溶级联反应的一种新决定因素)的检测
Clin Chem. 1999 Jun;45(6 Pt 1):807-13.
3
Carboxypeptidase U at the interface between coagulation and fibrinolysis.凝血与纤维蛋白溶解之间界面处的羧肽酶U
Clin Appl Thromb Hemost. 2001 Apr;7(2):93-101. doi: 10.1177/107602960100700203.
4
Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans.纤溶酶介导的血浆羧肽酶原B激活的特性。糖胺聚糖的调节作用。
J Biol Chem. 1999 Dec 3;274(49):35046-52. doi: 10.1074/jbc.274.49.35046.
5
[Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].[凝血酶激活的纤溶抑制物(TAFI)对纤溶系统的调节机制]
Nihon Yakurigaku Zasshi. 2000 Nov;116(5):298-303. doi: 10.1254/fpj.116.298.
6
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.凝血酶激活的纤溶抑制物(TAFI),即血浆羧肽酶原B,通过凝血酶-血栓调节蛋白复合物将凝血和纤溶级联反应联系起来。
J Biol Chem. 1996 Jul 12;271(28):16603-8. doi: 10.1074/jbc.271.28.16603.
7
Plasma carboxypeptidase U (CPU, CPB2, TAFIa) generation during in vitro clot lysis and its interplay between coagulation and fibrinolysis.体外血块溶解过程中血浆羧肽酶U(CPU、CPB2、TAFIa)的生成及其在凝血与纤溶之间的相互作用。
Thromb Haemost. 2017 Jul 26;117(8):1498-1508. doi: 10.1160/TH17-02-0097. Epub 2017 Jul 6.
8
Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway.凝血酶激活的纤维蛋白溶解抑制剂与抗纤维蛋白溶解途径。
Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2511-8. doi: 10.1161/01.atv.20.12.2511.
9
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.因因子V莱顿突变导致活化蛋白C抵抗的患者中凝血酶可激活纤溶抑制物抗原及TAFI活性
Thromb Res. 2002 Apr 1;106(1):59-62. doi: 10.1016/s0049-3848(02)00072-5.
10
Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U).凝血酶激活的纤维蛋白溶解抑制剂(TAFI,血浆羧肽酶原B、羧肽酶原R、羧肽酶原U)
Thromb Res. 2001 Mar 1;101(5):329-54. doi: 10.1016/s0049-3848(00)00411-4.

引用本文的文献

1
ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation.ProCPU 由(主要)人单核细胞和巨噬细胞表达,其表达在分化和激活状态之间存在差异。
Int J Mol Sci. 2023 Feb 13;24(4):3725. doi: 10.3390/ijms24043725.
2
Regulation of plasminogen activation on cell surfaces and fibrin.细胞表面和纤维蛋白上纤溶酶原激活的调节
J Thromb Haemost. 2018 May 20;16(8):1487-97. doi: 10.1111/jth.14157.
3
In vivo regulation of plasminogen function by plasma carboxypeptidase B.血浆羧肽酶B对纤溶酶原功能的体内调节
J Clin Invest. 2002 Nov;110(9):1275-82. doi: 10.1172/JCI15082.